Income Statement Mitani Corporation

Stocks

8066

JP3886800006

Construction Materials

Delayed Japan Exchange Other stock markets 00:41:15 2026-07-03 EDT			5-day change	1st Jan Change
2,683.00 ^JPY	+1.71%		+7.02%	+16.70%

24-12-25	Tranche Update on Mitani Corporation's Equity Buyback Plan announced on November 14, 2024.	CI
24-12-23	Mitani Corporation's Equity Buyback announced on November 14, 2024, has closed with 922,000 shares, representing 1.09% for ¥1,733.36 million.	CI

0b48be5e8fab934932729ac16b.2SGM68zVfPCPe1tYGuMvFKu1rWxAGKauIxTH-JP8i0M.rmD8ov-3CILsATZtX7RMTNP_lQowe-3CZHOSkqDF_RSTTPSygoI5v-YMbw

Published financial data: MITANI CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	397B	299B	320B	325B	339B
Total Revenues	397B	299B	320B	325B	339B
Cost of Goods Sold, Total	351B	252B	271B	270B	279B
Gross Profit	46.38B	46.93B	49.59B	54.36B	60.19B
Selling General & Admin Expenses, Total	24.01B	24.15B	25.9B	26.11B	26.81B
Provision for Bad Debts	-	-	-	-	-
R&D Expenses	103M	68M	75M	84M	98M
Depreciation & Amortization - (IS)	2.13B	2.06B	1.94B	2.34B	1.77B
Other Operating Expenses, Total	26.25B	26.27B	27.92B	28.53B	28.68B
Operating Income	20.13B	20.66B	21.68B	25.83B	31.51B
Interest Expense, Total	-79M	-89M	-121M	-193M	-193M
Interest And Investment Income	468M	260M	222M	935M	780M
Net Interest Expenses	389M	171M	101M	742M	587M
Income (Loss) On Equity Invest.	869M	-	992M	1.14B	847M
Currency Exchange Gains (Loss)	156M	663M	550M	1.16B	-
Other Non Operating Income (Expenses)	1.14B	1.2B	1.03B	850M	677M
EBT, Excl. Unusual Items	22.69B	22.69B	24.35B	29.72B	33.62B
Gain (Loss) On Sale Of Investments	-	44M	-	176M	53M
Gain (Loss) On Sale Of Assets	38M	-239M	-	-	224M
Asset Writedown	-1.4B	-583M	-363M	-774M	-1.02B
Other Unusual Items	-118M	-253M	-70M	283M	-1.46B
EBT, Incl. Unusual Items	21.21B	21.66B	23.91B	29.4B	31.42B
Income Tax Expense	7.6B	6.83B	7.12B	9.09B	9.82B
Earnings From Continuing Operations	13.6B	14.83B	16.8B	20.31B	21.6B
Net Income to Company	13.6B	14.83B	16.8B	20.31B	21.6B
Minority Interest	-1.15B	-1.75B	-1.93B	-2.14B	-2.58B
Net Income - (IS)	12.45B	13.08B	14.86B	18.17B	19.02B
Net Income to Common Incl Extra Items	12.45B	13.08B	14.86B	18.17B	19.02B
Net Income to Common Excl. Extra Items	12.45B	13.08B	14.86B	18.17B	19.02B
Per Share Items
Net EPS - Basic	128.36	139.45	165.6	203.62	222.44
Basic EPS - Continuing Operations	128.36	139.45	165.6	203.62	222.44
Basic Weighted Average Shares Outstanding	97M	93.77M	89.76M	89.22M	85.51M
Net EPS - Diluted	128.32	139.4	165.54	203.55	222.36
Diluted EPS - Continuing Operations	128.32	139.4	165.54	203.55	222.36
Diluted Weighted Average Shares Outstanding	97.03M	93.81M	89.79M	89.26M	85.55M
Normalized Basic EPS	134.35	132.53	148.01	184.14	215.59
Normalized Diluted EPS	134.3	132.48	147.95	184.07	215.51
Dividend Per Share	31.25	34	40	55	66
Payout Ratio	26.92	24	22.21	24.14	28.85
Supplemental Items
EBITDA	25.24B	25.97B	27.02B	31.57B	36.97B
EBITA	20.76B	21.18B	22.13B	26.57B	32B
EBIT	20.13B	20.66B	21.68B	25.83B	31.51B
EBITDAR	27.18B	27.96B	29.02B	33.59B	38.98B
Effective Tax Rate - (Ratio)	35.86	31.53	29.77	30.92	31.26
Normalized Net Income	13.03B	12.43B	13.29B	16.43B	18.44B
Non-Cash Pension Expense	179M	-614M	-32M	-137M	-895M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	103M	68M	75M	84M	98M
Net Rental Expense, Total	1.93B	1.99B	2B	2.02B	2.01B
Imputed Operating Lease Interest Expense	129M	159M	227M	399M	406M
Imputed Operating Lease Depreciation	1.8B	1.83B	1.77B	1.62B	1.6B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	93.18B	89.9B	100B	120B	128B
Total Cash And Short Term Investments	93.18B	89.9B	100B	120B	128B
Accounts Receivable, Total	75.94B	82.27B	87.2B	92.11B	86.67B
Total Receivables	75.94B	82.27B	87.2B	92.11B	86.67B
Inventory	9.05B	11.8B	14.51B	16.55B	16.22B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	7.04B	7.79B	7.78B	8.95B	9.54B
Total Current Assets	185B	192B	210B	238B	241B
Net Property Plant And Equipment	37.78B	37.96B	39.45B	37.65B	34.16B
Long-term Investments	16.6B	17.02B	16.61B	19.55B	19.84B
Goodwill	1.18B	887M	2.51B	1.72B	1.52B
Other Intangibles, Total	1.57B	1.35B	1.25B	994M	1.13B
Loans Receivable Long-Term	92M	92M	92M	98M	98M
Deferred Tax Assets Long-Term	1.12B	1.23B	1.21B	1.21B	1.35B
Other Long-Term Assets, Total	2M	2M	1M	1M	1M
Total Assets	244B	250B	271B	299B	299B
Liabilities
Accounts Payable, Total	52.38B	57.91B	60.63B	71.2B	62.92B
Accrued Expenses, Total	2.15B	2.25B	2.26B	2.33B	2.46B
Short-term Borrowings	4.64B	4.76B	6.07B	6.16B	6.64B
Current Income Taxes Payable	4.1B	3.43B	3.61B	5.78B	5.7B
Other Current Liabilities	13.04B	12.96B	17.04B	17.21B	17.91B
Total Current Liabilities	76.3B	81.32B	89.62B	103B	95.62B
Long-Term Debt	4.8B	3.68B	2.55B	822M	1.67B
Pension & Other Post Retirement Benefits	2.32B	2.43B	2.41B	2.49B	2.48B
Deferred Tax Liability Non Current	911M	1.47B	1.84B	2.34B	2.09B
Other Non Current Liabilities	5.08B	5.26B	5.2B	5.23B	4.96B
Total Liabilities	89.41B	94.17B	102B	114B	107B
Common Stock, Total	5.01B	5.01B	5.01B	5.01B	5.01B
Additional Paid In Capital	3.58B	3.61B	3.68B	4.04B	-
Retained Earnings	140B	150B	162B	175B	164B
Treasury Stock	-13.02B	-23.16B	-24.93B	-26.44B	-6.97B
Comprehensive Income and Other	758M	1.09B	2.2B	3.97B	4.89B
Total Common Equity	136B	136B	147B	162B	167B
Minority Interest	18.16B	19.68B	21.85B	23.62B	24.99B
Total Equity	154B	156B	169B	186B	192B
Total Liabilities And Equity	244B	250B	271B	299B	299B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	96.1M	90.51M	89.3M	88.48M	83.65M
ECS Total Common Shares Outstanding	96.1M	90.51M	89.3M	88.48M	83.65M
Book Value / Share	1.41K	1.51K	1.65K	1.83K	2K
Tangible Book Value	133B	134B	144B	159B	165B
Tangible Book Value Per Share	1.39K	1.48K	1.61K	1.8K	1.97K
Total Debt	9.44B	8.45B	8.62B	6.98B	8.31B
Net Debt	-83.74B	-81.46B	-91.71B	-113B	-120B
Debt Equivalent of Unfunded Proj. Benefit Obligation	244M	206M	15M	-900M	-1.26B
Debt Equivalent Oper. Leases	15.47B	15.94B	16B	16.15B	16.07B
Minority Interest, Total (Incl. Fin. Div)	18.16B	19.68B	21.85B	23.62B	24.99B
Inventories - Raw Materials, Total	2.07B	2.46B	2.89B	3.54B	4.11B
Inventories - Work In Process, Total	1.74B	1.9B	2.17B	1.89B	1.18B
Inventories - Finished Goods, Total	5.24B	7.44B	9.46B	11.12B	10.93B
Full Time Employees	1.99K	2K	2.06K	2.06K	2.08K
Accumulated Allowance for Doubtful Accounts (Supple)	90M	46M	117M	53M	86M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	21.21B	21.66B	23.91B	29.4B	31.42B
Depreciation & Amortization - CF	4.48B	4.79B	4.89B	5B	4.98B
Amortization of Goodwill and Intangible Assets - (CF)	632M	519M	452M	744M	487M
Depreciation & Amortization, Total	5.11B	5.31B	5.34B	5.74B	5.46B
(Gain) Loss From Sale Of Asset	1.4B	311M	44M	507M	1.02B
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-869M	32M	-992M	-1.14B	-847M
Other Operating Activities, Total	-6.4B	-7.06B	-6.5B	-6.94B	-9.47B
Change In Accounts Receivable	-3.07B	-6.07B	-3.82B	-4.34B	6.41B
Change In Inventories	97M	-2.64B	-1.74B	-1.72B	892M
Change In Accounts Payable	227M	5.46B	2.34B	10.48B	-8.41B
Change in Other Net Operating Assets	-1.25B	-212M	2.02B	-402M	-1.07B
Cash from Operations	16.46B	16.79B	20.6B	31.58B	25.42B
Capital Expenditure	-3.76B	-4.91B	-2.57B	-4.59B	-4.5B
Sale of Property, Plant, and Equipment	60M	19M	42M	136M	1.91B
Cash Acquisitions	-	-	-2.98B	-	-
Divestitures	-	-	12M	-	-
Investment in Marketable and Equity Securities, Total	-1.87B	-206M	-13.44B	-6.32B	-1.75B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-11M	-2M	-	-	-
Other Investing Activities, Total	-809M	-362M	-525M	-460M	-567M
Cash from Investing	-6.39B	-5.46B	-19.46B	-11.24B	-4.91B
Short Term Debt Issued, Total	670M	-	38M	-	1.72B
Long-Term Debt Issued, Total	900M	-	-	-	-
Total Debt Issued	1.57B	-	38M	-	1.72B
Short Term Debt Repaid, Total	-	-49M	-	-447M	-
Long-Term Debt Repaid, Total	-1.67B	-1.1B	-1.13B	-1.52B	-2.65B
Total Debt Repaid	-1.67B	-1.15B	-1.13B	-1.97B	-2.65B
Repurchase of Common Stock	-4.21B	-10.15B	-757M	-1.51B	-7.91B
Common Dividends Paid	-3.35B	-3.14B	-3.3B	-4.38B	-5.49B
Common & Preferred Stock Dividends Paid	-3.35B	-3.14B	-3.3B	-4.38B	-5.49B
Other Financing Activities, Total	-583M	-808M	-341M	-313M	-658M
Cash from Financing	-8.25B	-15.25B	-5.49B	-8.18B	-14.99B
Foreign Exchange Rate Adjustments	95M	585M	1.09B	1.07B	921M
Miscellaneous Cash Flow Adjustments	1.06B	51M	151M	-	-1M
Net Change in Cash	2.97B	-3.29B	-3.12B	13.23B	6.44B
Supplemental Items
Cash Interest Paid	80M	80M	131M	183M	211M
Cash Income Tax Paid (Refund)	6.52B	7.22B	6.64B	7.12B	9.87B
Levered Free Cash Flow	9.47B	8.32B	15.6B	22.01B	18.19B
Unlevered Free Cash Flow	9.52B	8.38B	15.68B	22.13B	18.31B
Change In Net Working Capital	4.42B	4.93B	642M	-4.84B	2.34B
Net Debt Issued / Repaid	-103M	-1.15B	-1.09B	-1.97B	-930M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.29	5.23	5.2	5.66	6.59
Return on Total Capital	7.85	7.87	7.91	8.72	10.02
Return On Equity %	9.02	9.56	10.32	11.45	11.44
Return on Common Equity	9.34	9.6	10.47	11.74	11.56
Margin Analysis
Gross Profit Margin %	11.68	15.68	15.48	16.74	17.75
SG&A Margin	6.05	8.07	8.09	8.04	7.91
EBITDA Margin %	6.36	8.67	8.44	9.72	10.91
EBITA Margin %	5.23	7.07	6.91	8.18	9.44
EBIT Margin %	5.07	6.9	6.77	7.95	9.29
Income From Continuing Operations Margin %	3.43	4.95	5.24	6.25	6.37
Net Income Margin %	3.14	4.37	4.64	5.59	5.61
Net Avail. For Common Margin %	3.14	4.37	4.64	5.59	5.61
Normalized Net Income Margin	3.28	4.15	4.15	5.06	5.44
Levered Free Cash Flow Margin	2.38	2.78	4.87	6.78	5.37
Unlevered Free Cash Flow Margin	2.4	2.8	4.9	6.82	5.4
Asset Turnover
Asset Turnover	1.67	1.21	1.23	1.14	1.13
Fixed Assets Turnover	10.86	7.9	8.27	8.42	9.44
Receivables Turnover (Average Receivables)	5.37	3.78	3.78	3.62	3.79
Inventory Turnover (Average Inventory)	39.6	24.21	20.58	17.41	17.01
Short Term Liquidity
Current Ratio	2.43	2.36	2.34	2.32	2.52
Quick Ratio	2.22	2.12	2.09	2.07	2.25
Operating Cash Flow to Current Liabilities	0.22	0.21	0.23	0.31	0.27
Days Sales Outstanding (Average Receivables)	67.94	96.45	96.57	101.04	96.24
Days Outstanding Inventory (Average Inventory)	9.22	15.08	17.74	21.02	21.45
Average Days Payable Outstanding	54.1	78.88	79.13	88.54	87.89
Cash Conversion Cycle (Average Days)	23.06	32.65	35.17	33.51	29.81
Long Term Solvency
Total Debt/Equity	6.12	5.41	5.09	3.76	4.32
Total Debt / Total Capital	5.77	5.13	4.85	3.63	4.15
LT Debt/Equity	3.11	2.36	1.51	0.44	0.87
Long-Term Debt / Total Capital	2.93	2.24	1.44	0.43	0.83
Total Liabilities / Total Assets	36.71	37.62	37.51	37.97	35.73
EBIT / Interest Expense	254.84	232.1	179.13	133.83	163.26
EBITDA / Interest Expense	319.56	291.75	223.28	163.58	191.56
(EBITDA - Capex) / Interest Expense	271.96	236.57	202.06	139.78	168.25
Total Debt / EBITDA	0.37	0.33	0.32	0.22	0.22
Net Debt / EBITDA	-3.32	-3.14	-3.39	-3.59	-3.25
Total Debt / (EBITDA - Capex)	0.44	0.4	0.35	0.26	0.26
Net Debt / (EBITDA - Capex)	-3.9	-3.87	-3.75	-4.2	-3.7
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-3.79	-24.59	6.99	1.4	4.38
Gross Profit, 1 Yr. Growth %	3.64	1.19	5.68	9.6	10.73
EBITDA, 1 Yr. Growth %	7.08	2.86	4.05	16.85	17.11
EBITA, 1 Yr. Growth %	7.14	1.98	4.49	20.09	20.41
EBIT, 1 Yr. Growth %	7.15	2.61	4.93	19.16	21.99
Earnings From Cont. Operations, 1 Yr. Growth %	11.59	9.02	13.27	20.94	6.33
Net Income, 1 Yr. Growth %	19.26	5.02	13.67	22.22	4.71
Normalized Net Income, 1 Yr. Growth %	20.25	-4.64	6.9	23.67	12.22
Diluted EPS Before Extra, 1 Yr. Growth %	21.93	8.63	18.75	22.96	9.24
Accounts Receivable, 1 Yr. Growth %	5.71	8.33	6	5.63	-5.91
Inventory, 1 Yr. Growth %	4.6	30.36	22.97	14.07	-1.98
Net Property, Plant and Equip., 1 Yr. Growth %	6.95	0.5	3.91	-4.55	-9.29
Total Assets, 1 Yr. Growth %	4.98	2.77	8.25	10.37	-0.02
Tangible Book Value, 1 Yr. Growth %	3.85	0.74	7.09	10.75	3.36
Common Equity, 1 Yr. Growth %	4.06	0.35	8.09	9.76	3.27
Cash From Operations, 1 Yr. Growth %	44.08	2.01	22.66	53.33	-19.52
Capital Expenditures, 1 Yr. Growth %	-22.54	30.61	-47.71	78.86	-2.05
Levered Free Cash Flow, 1 Yr. Growth %	52.12	-12.08	87.47	41.08	-17.36
Unlevered Free Cash Flow, 1 Yr. Growth %	51.42	-11.95	87.13	41.17	-17.26
Dividend Per Share, 1 Yr. Growth %	13.64	8.8	17.65	37.5	20
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-2.53	-14.82	-10.18	4.16	2.88
Gross Profit, 2 Yr. CAGR %	2.3	2.4	3.41	7.62	10.17
EBITDA, 2 Yr. CAGR %	4.28	4.95	3.45	10.26	16.98
EBITA, 2 Yr. CAGR %	3.49	4.53	3.23	12.02	20.25
EBIT, 2 Yr. CAGR %	3.55	4.85	3.76	11.82	20.57
Earnings From Cont. Operations, 2 Yr. CAGR %	-2.21	10.3	11.12	17.04	13.4
Net Income, 2 Yr. CAGR %	0.21	11.91	9.26	17.87	13.13
Normalized Net Income, 2 Yr. CAGR %	9.11	7.08	0.97	14.98	17.8
Diluted EPS Before Extra, 2 Yr. CAGR %	1.58	15.09	13.58	20.84	15.9
Accounts Receivable, 2 Yr. CAGR %	-3.89	7.01	7.16	5.81	-0.31
Inventory, 2 Yr. CAGR %	-2.75	16.77	26.61	18.43	5.74
Net Property, Plant and Equip., 2 Yr. CAGR %	4.37	3.68	2.19	-0.41	-6.95
Total Assets, 2 Yr. CAGR %	0.31	3.87	5.48	9.31	5.04
Tangible Book Value, 2 Yr. CAGR %	5.1	2.28	3.86	8.9	6.99
Common Equity, 2 Yr. CAGR %	4.95	2.18	4.15	8.92	6.46
Cash From Operations, 2 Yr. CAGR %	-8.79	21.24	11.86	37.14	11.08
Capital Expenditures, 2 Yr. CAGR %	4.61	0.59	-17.36	-3.29	32.36
Levered Free Cash Flow, 2 Yr. CAGR %	-22.58	15.65	28.39	62.63	7.98
Unlevered Free Cash Flow, 2 Yr. CAGR %	-22.56	15.47	28.36	62.53	8.07
Dividend Per Share, 2 Yr. CAGR %	33.63	11.19	13.14	27.19	28.45
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.46	-10.52	-8.1	-6.47	4.23
Gross Profit, 3 Yr. CAGR %	4.02	1.93	3.48	5.43	8.65
EBITDA, 3 Yr. CAGR %	6.68	3.8	4.65	7.74	12.5
EBITA, 3 Yr. CAGR %	6.7	2.98	4.52	8.57	14.75
EBIT, 3 Yr. CAGR %	6.81	3.24	4.88	8.66	15.11
Earnings From Cont. Operations, 3 Yr. CAGR %	5.02	1.4	11.28	14.3	13.36
Net Income, 3 Yr. CAGR %	7.92	1.79	12.5	13.42	13.31
Normalized Net Income, 3 Yr. CAGR %	12.56	4.32	7.02	8.03	14.05
Diluted EPS Before Extra, 3 Yr. CAGR %	9.36	3.88	16.3	16.62	16.84
Accounts Receivable, 3 Yr. CAGR %	-1.45	0.02	6.67	6.64	1.75
Inventory, 3 Yr. CAGR %	9.88	7.22	18.8	22.28	11.2
Net Property, Plant and Equip., 3 Yr. CAGR %	3.18	3.06	3.75	-0.11	-3.46
Total Assets, 3 Yr. CAGR %	2.62	1.12	5.31	7.08	6.1
Tangible Book Value, 3 Yr. CAGR %	6.36	3.62	3.86	6.11	7.02
Common Equity, 3 Yr. CAGR %	6.15	3.39	4.12	5.99	7
Cash From Operations, 3 Yr. CAGR %	-14.51	-5.32	21.71	24.26	14.82
Capital Expenditures, 3 Yr. CAGR %	-9.32	12.64	-19.12	6.9	-2.88
Levered Free Cash Flow, 3 Yr. CAGR %	-12.47	-19.23	35.85	32.49	29.78
Unlevered Free Cash Flow, 3 Yr. CAGR %	-12.45	-19.17	35.63	32.5	29.78
Dividend Per Share, 3 Yr. CAGR %	36.64	24.78	13.3	20.74	24.74
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.14	-3.7	-3.36	-4.91	-3.85
Gross Profit, 5 Yr. CAGR %	1.79	2.87	3.78	4.17	6.11
EBITDA, 5 Yr. CAGR %	0.75	5.02	5.37	6.34	9.42
EBITA, 5 Yr. CAGR %	0.22	4.79	5.3	6.51	10.55
EBIT, 5 Yr. CAGR %	-0.18	4.69	5.58	6.59	10.89
Earnings From Cont. Operations, 5 Yr. CAGR %	1.11	4.01	7.42	7.39	12.12
Net Income, 5 Yr. CAGR %	1.9	4.57	8.45	7.94	12.75
Normalized Net Income, 5 Yr. CAGR %	2.47	5.82	7.77	8.46	11.21
Diluted EPS Before Extra, 5 Yr. CAGR %	3.75	6.58	11.03	10.36	16.14
Accounts Receivable, 5 Yr. CAGR %	0.33	1.45	1.9	2.3	3.82
Inventory, 5 Yr. CAGR %	7.09	19.71	16.29	11.57	13.39
Net Property, Plant and Equip., 5 Yr. CAGR %	1.74	1.89	2.78	1.66	-0.67
Total Assets, 5 Yr. CAGR %	5.11	4.34	3.76	4.32	5.2
Tangible Book Value, 5 Yr. CAGR %	6.53	4.96	5.36	5.7	5.1
Common Equity, 5 Yr. CAGR %	6.65	5.05	5.35	5.57	5.05
Cash From Operations, 5 Yr. CAGR %	0.99	4.03	-4.81	9.8	17.34
Capital Expenditures, 5 Yr. CAGR %	7.21	8.02	-12.62	5.98	-1.51
Levered Free Cash Flow, 5 Yr. CAGR %	-5.14	-12.7	2.02	6.87	23.93
Unlevered Free Cash Flow, 5 Yr. CAGR %	-5.14	-12.64	2.03	6.89	23.85
Dividend Per Share, 5 Yr. CAGR %	28.27	29.05	26.7	25.74	19.14